Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis. 2022

Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
Department of Clinical Nutrition and Dietetics, Konan Women's University.

We aimed to verify antitumor effects of zinc acetate on hepatocellular carcinoma (HCC) in vitro. Five HCC cell lines (HepG2, Hep3B, Huh7, HLE and Alex) were used to evaluate the antitumor effects of zinc acetate. Cell viability was determined by the Cell Counting Kit-8 assay. The cell-cycle alteration was evaluated by a flow cytometric analysis and the detection of cell cycle-related proteins. Apoptosis was determined based on the caspase-cleaved cytokeratin 18 (cCK18) levels. The microRNAs (miRNAs) related to an antitumor effect of zinc acetate were identified using microarrays. Zinc acetate significantly inhibited the proliferation of HCC cells in a dose-dependent manner. The treatment with zinc acetate resulted in significantly increased cCK18 levels in the supernatant and enhanced the expression of heme oxygenase-1 (HO-1) in HCC cells. The flow cytometric analysis revealed an increase of HCC cells in the S and G2/M phases by the administration of zinc acetate, and the expressions of Cdk2 and cyclin E were increased. The miRNA expression profile of the HCC cells treated with zinc acetate was extremely different from that of the untreated HCC cells. These results suggest that the zinc acetate supplementation induces the apoptosis of HCC cells, but does not affect the cell cycle progression. Upregulation of HO-1 and the alteration of miRNAs' profile may be involved in antitumor effects of zinc acetate in HCC cells.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell
D019345 Zinc Acetate A salt produced by the reaction of zinc oxide with acetic acid and used as an astringent, styptic, and emetic. Anhydrous Zinc Acetate,Galzin,Zinc Acetate Anhydrous,Zinc Acetate Dihydrate,Zinc Acetate, Anhydrous
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
August 2002, Japanese journal of cancer research : Gann,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
January 1999, International journal of oncology,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
January 2022, International journal of molecular sciences,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
June 2012, Molecular medicine reports,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
November 2004, Ai zheng = Aizheng = Chinese journal of cancer,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
December 2016, The Journal of international medical research,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
January 2014, TheScientificWorldJournal,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
November 2022, International journal of molecular sciences,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
May 2021, Chemistry & biodiversity,
Rie Hashimoto, and Takashi Himoto, and Mari Yamada, and Shima Mimura, and Koji Fujita, and Joji Tani, and Asahiro Morishita, and Tsutomu Masaki
October 2014, The Journal of surgical research,
Copied contents to your clipboard!